Alex R. Thurman - Mar 14, 2024 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Signature
Diana Scherer, Attorney-in-Fact
Stock symbol
GKOS
Transactions as of
Mar 14, 2024
Transactions value $
$0
Form type
4
Date filed
3/18/2024, 07:56 PM
Previous filing
Feb 9, 2024
Next filing
Apr 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GKOS Common Stock Award $0 +4.96K +9.17% $0.00 59K Mar 14, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GKOS Stock Option (Right to Buy) Award $0 +1.83K +8.7% $0.00 22.9K Mar 14, 2024 Common Stock 1.83K $55.18 Direct F3, F4
transaction GKOS Stock Option (Right to Buy) Award $0 +8.91K $0.00 8.91K Mar 14, 2024 Common Stock 1.83K $49.51 Direct F5, F6
transaction GKOS Stock Option (Right to Buy) Award $0 +8.59K $0.00 8.59K Mar 14, 2024 Common Stock 8.59K $85.78 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date.
F2 Includes 32,599 restricted stock units that have not yet vested or been delivered to the Reporting Person.
F3 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 14, 2024 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.
F4 50% of the portion of the option reported herein will vest and become exercisable in March 2024, and the remaining 50% will vest and become exercisable in December 2024.
F5 Represents an option to purchase shares of common stock previously granted by the Issuer on April 3, 2023 pursuant to the Reporting Person's election to receive a portion of his annual bonus for 2023 in the form of stock options rather than cash (the "Bonus Election"). The Compensation Committee determined on March 14, 2024 the annual bonus payable to the Reporting Person pursuant to the Issuer's 2023 executive bonus plan and the number of shares of common stock subject to the stock option earned by the Reporting Person in accordance with the Bonus Election, subject to continued employment through the vesting date.
F6 The option to purchase common stock will vest on April 1, 2024.
F7 This option was granted on March 14, 2024 and has a four-year vesting schedule in which 25% vests on the first anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date.